Details for Australian Trade Mark No. 1275266 (hide)

Owner Santhera Pharmaceuticals (Schweiz) AG

Convention CA 6 June 2008 1398491

Service MINTER ELLISON Attention: Grant Williams Rialto Towers **** Street MELBOURNE VIC 3000

Filing Date 3 December 2008

Classes

Class 5 Pharmaceutical preparations for the treatment of neurological and muscular diseases, namely muscular dystrophy, ataxias, Lou Gerig's disease, Parkinson, Huntington disease, spinal muscular atrophies, polyneurophaties, fibromyalgia, monoeuropathies, neuromuscular junction disorders, myotonia and myopathie, and pharmaceutical preparations for medical purposes for the treatment of ophthalmologic diseases

Class 42 Scientific and industrial research services in the fields of cell cultures, cellular test systems for evaluating drugs, antibodies, test systems for detecting pharmacologically active compounds, animal models, neurological and muscular diseases, and ophthalmologic diseases, and the treatment of such diseases; computer programming services in the fields of cell cultures, cellular test systems for evaluating drugs, antibodies, test systems for detecting pharmacologically active compounds, animal models, neurological and muscular diseases, and ophthalmologic diseases, and the treatment of such diseases

Event Publications

8 January 2009 Application filed

8 January 2009 Application Accepted

7 May 2009 Trade Mark Registered/Protected

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the ATMOSS Australian Trade Mark On-line Search System.

Next and Previous Trademarks/Applications

1275267

1275265-CAMPUS